Strategic Partnership Channel OrthAlign recently added Brett Brodnax, Executive Chairman of USPI, to its Board. This signals closer access to a large hospital network and potential collaboration with USPI affiliated facilities for joint replacement technology adoption. Sales approach: engage senior hospital administrators and surgeons with ROI focused briefings and clinical case studies.

European Distribution Growth OrthAlign already partners with Lima Corporate for European distribution, showing an established route to European markets. There is an opportunity to expand co selling with Lima Corporate and leverage their network to reach additional hospitals and distributors in Europe. Action: align regulatory readiness and local clinical champions for faster market access.

Global Market Expansion The Lantern handheld technology has been launched in Japan and expanded across knee procedures. This demonstrates a global growth trajectory and readiness of markets outside the US. Potential sales focus on large orthopedic centers in target regions with a track record of adopting advanced navigation tools; tailor training and onboarding packages.

Credible Innovation OrthAlign has earned industry recognition including an AAHKS Industry Innovation Award and a Top Places to Work designation. These credentials help build trust with procurement and clinical leaders. Use in sales collateral and RFP responses as proof points for value and reliability.

Value Proposition The product portfolio covers partial knee, total knee, and total hip replacements with live navigation and soft tissue balancing features. The Balance feature on Lantern enhances surgical precision in primary and revision procedures. With a revenue size in the mid-market range, target mid to large orthopedic centers with cost-effective navigation that can reduce training and operational burdens; propose ROI-focused proposals and bundled service options.